Correlation Between 651639AZ9 and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both 651639AZ9 and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 651639AZ9 and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NEM 26 15 JUL 32 and Apogee Therapeutics, Common, you can compare the effects of market volatilities on 651639AZ9 and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 651639AZ9 with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of 651639AZ9 and Apogee Therapeutics,.

Diversification Opportunities for 651639AZ9 and Apogee Therapeutics,

-0.64

Correlation Coefficient

651639AZ9  Apogee Therapeutics,

Excellent diversification

The 3 months correlation between 651639AZ9 and Apogee is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding NEM 26 15 JUL 32 and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and 651639AZ9 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NEM 26 15 JUL 32 are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of 651639AZ9 i.e., 651639AZ9 and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between 651639AZ9 and Apogee Therapeutics,

Assuming the 90 days trading horizon NEM 26 15 JUL 32 is expected to generate 0.14 times more return on investment than Apogee Therapeutics,. However, NEM 26 15 JUL 32 is 7.07 times less risky than Apogee Therapeutics,. It trades about -0.07 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.03 per unit of risk. If you would invest  8,517  in NEM 26 15 JUL 32 on December 25, 2024 and sell it today you would lose (217.00) from holding NEM 26 15 JUL 32 or give up 2.55% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.33%
Values	Daily Returns

NEM 26 15 JUL 32  vs.  Apogee Therapeutics, Common

NEM 26 15

Risk-Adjusted Performance

Very Weak

Over the last 90 days NEM 26 15 JUL 32 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 651639AZ9 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Apogee Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with 651639AZ9 and Apogee Therapeutics,

The main advantage of trading using opposite 651639AZ9 and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 651639AZ9 position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind NEM 26 15 JUL 32 and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.